Latest Insider Transactions at Invo Bioscience, Inc. (INVO)
This section provides a real-time view of insider transactions for Invo Bioscience, Inc. (INVO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INVO Bioscience, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INVO Bioscience, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Kevin Doody Medical Director |
SELL
Open market or private purchase
|
Direct |
177,306
-100.0%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Rebecca Messina Director |
BUY
Open market or private purchase
|
Direct |
9,868
+29.98%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Andrea Goren Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
52,632
+28.97%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Michael Jos. Campbell Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
10,526
+12.2%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Jeffrey Segal Director |
BUY
Open market or private purchase
|
Direct |
9,211
+24.61%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Trent D Davis Director |
BUY
Open market or private purchase
|
Direct |
11,184
+24.96%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Barbara Ryan Director |
BUY
Open market or private purchase
|
Direct |
10,526
+31.41%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Matthew K Szot Director |
BUY
Open market or private purchase
|
Direct |
14,474
+26.98%
|
$0
$0.95 P/Share
|
|
Jun 01
2022
|
Steve Shum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
58,885
+31.44%
|
$0
$0.95 P/Share
|
|
Jan 15
2022
|
Andrea Goren Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,361
+23.09%
|
-
|
|
Jan 15
2022
|
Barbara Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,588
+28.97%
|
-
|
|
Jan 15
2022
|
Rebecca Messina Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,311
+38.68%
|
-
|
|
Jan 15
2022
|
Matthew K Szot Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,250
+29.33%
|
-
|
|
Jan 15
2022
|
Steve Shum Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,111
+19.69%
|
-
|
|
Jan 15
2022
|
Michael Jos. Campbell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,236
+18.93%
|
-
|
|
Jan 15
2022
|
Jeffrey Segal Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,034
+30.85%
|
-
|
|
Jan 15
2022
|
Kevin Doody Medical Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,480
+4.05%
|
-
|
|
Jan 15
2022
|
Trent D Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,865
+28.32%
|
-
|
|
Oct 05
2021
|
Steve Shum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
30,674
+33.13%
|
$92,022
$3.26 P/Share
|
|
Oct 05
2021
|
Andrea Goren Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
30,674
+28.65%
|
$92,022
$3.26 P/Share
|
|
May 11
2021
|
Rebecca Messina Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,806
+50.0%
|
-
|
|
May 10
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.09%
|
$3,000
$3.76 P/Share
|
|
May 06
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.09%
|
$3,000
$3.85 P/Share
|
|
May 04
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,922
+0.13%
|
$8,766
$3.85 P/Share
|
|
Apr 27
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,800
+0.33%
|
$15,200
$4.44 P/Share
|
|
Apr 20
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,500
+0.3%
|
$10,500
$3.9 P/Share
|
|
Apr 19
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,801
+0.5%
|
$17,403
$3.64 P/Share
|
|
Apr 16
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,001
+0.78%
|
$27,003
$3.83 P/Share
|
|
Apr 15
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
322
+0.03%
|
$966
$3.85 P/Share
|
|
Apr 14
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
17,152
+1.49%
|
$51,456
$3.95 P/Share
|
|
Apr 13
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,800
+0.52%
|
$17,400
$3.97 P/Share
|
|
Apr 12
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,146
+1.17%
|
$52,584
$4.0 P/Share
|
|
Apr 09
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
27,811
+2.48%
|
$111,244
$4.08 P/Share
|
|
Apr 08
2021
|
Awm Investment Company, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,000
+1.39%
|
$60,000
$4.08 P/Share
|
|
Dec 31
2020
|
Trent D Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,475
+43.56%
|
-
|
|
Dec 31
2020
|
Kevin Doody Medical Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,184
+4.6%
|
-
|
|
Dec 31
2020
|
Barbara Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,148
+44.88%
|
-
|
|
Dec 31
2020
|
Jeffrey Segal Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,838
+46.98%
|
-
|
|
Dec 31
2020
|
Matthew K Szot Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,112
+45.6%
|
-
|
|
Nov 27
2020
|
Barbara Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+50.0%
|
-
|
|
Nov 27
2020
|
Jeffrey Segal Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+50.0%
|
-
|
|
Nov 27
2020
|
Matthew K Szot Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,339
+50.0%
|
-
|